Please login to the form below

Not currently logged in
Email:
Password:

Crescendo Biologics appoints Edward Stewart as chief business officer

He joins the Cambridge, UK-based firm from Merrimack Pharmaceuticals

Biopharmaceutical group Crescendo Biologics has appointed Edward Stewart as its new chief business officer.

Stewart joins the Cambridge, UK-based firm from Merrimack Pharmaceuticals, where he served in several executive roles, including leading the commercial business unit and the business development function.

He said: “Crescendo is developing very exciting and highly differentiated pipeline of therapeutics.

“I look forward to joining the team and contributing my experience to advance those products, achieve our corporate goals and realise the full potential of the Humabody platform.”

Stewart has over 20 years’ of experience working in the biotechnology field and his expertise lies in growing pre-clinical organisations to commercial enterprises and market launches.

Peter Pack, CEO of Crescendo Biologics, said: “A strong and experienced team is key to reaching our ambitions and Stewart brings broad experience in business and corporate development as well as organisational growth, making him a great addition to our leadership team.”

20th June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics